SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE L impact

BillionToOne launches Northstar Origin liquid biopsy add-on test

BillionToOne introduced Northstar Origin, an add-on test using a single blood draw, to help identify tissue of origin. It also expanded the Northstar Select panel to 102 genes.

BLLN

New add-on test from a single blood draw; BillionToOne also expands Northstar Select® panel to 102 genesMENLO PARK, Calif., Sept.

1, 2026 // -- BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are…